Australia’s Cauldron Ferm Gets $13.25M for Continuous ‘Hyper-Fermentation’ Platform
Cauldron Ferm, an Australian innovator in biomanufacturing, has successfully closed a Series A2 funding round, raising $13.25 million. This significant…
Cauldron Ferm, an Australian innovator in biomanufacturing, has successfully closed a Series A2 funding round, raising $13.25 million. This significant…
The medical aesthetics sector is currently undergoing a period of unprecedented growth and professionalization, driven by technological innovation and an…